APELLIS PHARMACEUTICALS INC. - COMMON STOCK
28.33
14-11月-24 11:03:38
15 分の遅延
株式
+0.08
+0.28%
本日の幅
27.81 - 28.49
ISIN
N/A
ソース
NASDAQ
-
Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
07 5 2024 07:05:00 提供 Nasdaq GlobeNewswire
-
06 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
01 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
26 4 2024 07:15:00 提供 Nasdaq GlobeNewswire
-
23 4 2024 07:00:14 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 4 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
01 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
11 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 3 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
27 2 2024 07:05:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
26 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
20 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 2 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
26 1 2024 07:06:23 提供 Nasdaq GlobeNewswire
-
Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues
08 1 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 1 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
28 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Apellis Provides Update on Ongoing Regulatory Review of Pegcetacoplan for GA in the European Union
14 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
11 12 2023 07:00:00 提供 Nasdaq GlobeNewswire